Childhood Type 1 Diabetes Tied to Higher Risk of Later Psychiatric Diagnoses
By Lori Solomon HealthDay Reporter
THURSDAY, July 25, 2024 -- A childhood diagnosis of type 1 diabetes (T1D) may increase risk of later psychiatric conditions, according to a study published online July 17 in Nature Mental Health.
Tomáš Formánek, from the University of Cambridge in the United Kingdom, and colleagues used Czech national register data to identify children (aged ≤14 years) with T1D between 1994 and 2007. Risk of psychiatric disorders up to 24 years later was assessed.
The researchers found that children diagnosed with T1D had an elevated risk of developing substance use, mood, anxiety and personality disorders, and behavioral syndromes. However, children with T1D had a lower risk of developing psychotic disorders. An association with schizophrenia was identified in Mendelian randomization analysis, but did not persist following multiple testing adjustment.
"The combined observational and Mendelian randomization evidence suggests that T1D diagnosis in childhood predisposes to far-reaching, extensive psychiatric morbidity, which is unlikely to be explicable by common underlying biological mechanisms," the authors write. "The findings of this study highlight that monitoring and addressing the mental health needs of children with T1D is imperative, whereas glucose dysregulation and/or inflammation implicated in schizophrenia pathogenesis warrants future research."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Worse Mental Health Trajectories Seen for Survivors of Teen, Young Adult Cancer
WEDNESDAY, May 28, 2025 -- Survivors of adolescent and young adulthood (AYA) cancer have significantly worse mental health trajectories into middle or older adulthood, according...
American Psychiatric Association, May 17-21
The annual meeting of the American Psychiatric Association was held from May 17 to 21 in Los Angeles. Participants included clinicians, academicians, allied health...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.